Search Results - "DOBRINSKA, M. R"
-
1
Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
Published in The American journal of cardiology (01-10-1999)“…The long-term safety profile of simvastatin, established over 10 years of clinical use, is excellent. The principal adverse effect of all inhibitors of…”
Get full text
Journal Article -
2
The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day
Published in The American journal of cardiology (01-01-1997)“…The hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin is the most effective of the currently approved hypolipidemic drugs and has been shown to…”
Get full text
Journal Article -
3
Use of In Vitro Drug Metabolism Data to Evaluate Metabolic Drug-Drug Interactions in Man: The Need for Quantitative Databases
Published in Journal of clinical pharmacology (01-04-2001)“…It has become widely accepted that metabolic drug‐drug interactions can be forecast using in vitro cytochrome P450 (CYP) data. For any CYP form‐inhibitor pair,…”
Get full text
Journal Article -
4
Evaluation of orally administered highly variable drugs and drug formulations
Published in Pharmaceutical research (01-11-1996)Get full text
Journal Article -
5
Fully automated methods for the determination of hydrochlorothiazide in human plasma and urine
Published in Journal of pharmaceutical and biomedical analysis (01-12-1994)“…LC assays utilizing fully automated sample preparation procedures on Zymark PyTechnology Robot and BenchMate Workstation for the quantification of…”
Get more information
Journal Article -
6
Enterohepatic circulation of drugs
Published in Journal of clinical pharmacology (01-07-1989)Get more information
Journal Article -
7
Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin
Published in Pharmaceutical research (01-12-1992)“…The effects of age and of gender on the plasma profiles of HMG-CoA reductase inhibitors following separate once-a-day dosage regimens (17 days) of lovastatin…”
Get full text
Journal Article -
8
The Use of Stable Isotope Labeling and Liquid Chromatography/Tandem Mass Spectrometry Techniques to Study the Pharmacokinetics and Bioavailability of the Antimigraine Drug, MK-0462 (Rizatriptan) in Dogs
Published in Rapid communications in mass spectrometry (1996)“…MK‐0462 (rizatriptan) is a 5HT1D agonist being developed for the treatment of migraine. The assay for this substance in plasma and urine is based on HPLC with…”
Get full text
Journal Article -
9
An automated sample preparation and high performance liquid chromatographic method for the determination of MK-591, a novel leukotriene biosynthesis inhibitor, in human plasma
Published in Journal of pharmaceutical and biomedical analysis (01-08-1996)“…A high performance liquid chromatography assay utilizing an automated sample preparation procedure for the determination of a novel leukotriene biosynthesis…”
Get full text
Journal Article -
10
Biotransformation of sulindac in end-stage renal disease
Published in Clinical pharmacology and therapeutics (01-07-1987)“…In normal humans sulindac, a prodrug, undergoes two major biotransformations: irreversible oxidation to the inactive sulfone metabolite and reversible…”
Get more information
Journal Article -
11
Bioavailability of fluvoxamine given with and without food
Published in Biopharmaceutics & drug disposition (01-11-1991)“…The influence of concomitant food intake on plasma concentrations of the antidepressant drug fluvoxamine maleate was investigated in a two-way, crossover study…”
Get more information
Journal Article -
12
Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys
Published in Drug metabolism and disposition (01-01-1982)“…The physiological disposition following intravenous dosing of the separate enantiomers of indacrinone-14C (I), and of their major metabolite,…”
Get more information
Journal Article -
13
Sensitive high-performance liquid chromatographic assay using electrochemical detection for a novel prodrug ester of methyldopa, pivaloyloxyethyl 3-(3,4-dihydroxyphenyl)-2-methylalaninate, in plasma and urine
Published in Journal of chromatography (08-06-1984)“…The pivaloyloxyethyl ester of methyldopa is an antihypertensive prodrug possessing improved bioavailability properties over methyldopa. A sensitive…”
Get more information
Journal Article -
14
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration
Published in Pharmacogenetics (London) (01-12-2001)“…We investigated whether a single plasma midazolam concentration could serve as an accurate predictor of total midazolam clearance, an established in-vivo probe…”
Get full text
Journal Article -
15
Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detection
Published in Journal of chromatography. B, Biomedical applications (21-04-1995)“…Sensitive methods based on capillary gas chromatography (GC) with mass spectrometric (MS) detection in a selected-ion monitoring mode (SIM) for the…”
Get full text
Journal Article -
16
Biliary secretion of sulindac and metabolites in man
Published in Biopharmaceutics & drug disposition (01-10-1983)“…The biliary secretion of sulindac and metabolites after a single 400 mg oral dose of the drug was studied in 3 elective gallbladder surgical patients following…”
Get more information
Journal Article -
17
Enterohepatic circulation of sulindac and metabolites
Published in Clinical pharmacology and therapeutics (01-02-1983)“…Four subjects were studied by continuous intraduodenal sampling to establish the existence and determine the extent of enterohepatic recirculation of sulindac…”
Get more information
Journal Article -
18
Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester
Published in Drug metabolism and disposition (01-03-1984)“…In a crossover study, the pivaloyloxyethyl ester (POE) of methyldopa, labeled either with 3H in the methyldopa moiety or 14C in the pivalic acid moiety, was…”
Get more information
Journal Article -
19
Blood levels from a sustained-release dosage form
Published in Journal of pharmaceutical sciences (01-10-1975)Get more information
Journal Article -
20
Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopa
Published in Journal of pharmacokinetics and biopharmaceutics (01-12-1982)“…A prodrug of methyldopa, the pivaloyloxyethyl (POE) ester, was administered orally to healthy human volunteers at doses equivalent to 500 and 1000 mg of…”
Get more information
Journal Article